Guidelines on Management of Cancer Pain: Bibliography
American Society of Anesthesiologists
1. Adams F, Cruz L, Deachman MJ, Zamora E: Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain. Journal of Pain & Symptom Management 4:31-33, 1989
2. Aguilar JL, Montes A, Samper D, Roca G, Vidal F: Interpleural analgesia through a DuPen catheter for lung cancer pain. Cancer 70:2621-2623, 1992
3. Ahlgren FI, Ahlgren MB: Epidural administration of opiates by a new device. Pain 31:353-357, 1987
4. Ali NM, Hanna N, Hoffman JS: Percutaneous epidural catheterization for intractable pain in terminal cancer patients. Gynecologic Oncology 32:22-25, 1989
5. Ali NM, Hoffman JS: Tolerance during long-term administration of intrathecal morphine. Connecticut Medicine 53:266-268, 1989
6. Allum WH, Mack P, Priestman TJ, Fielding JW: Radiotherapy for pain relief in locally recurrent colorectal cancer. Annals of the Royal College of Surgeons of England 69:220-221, 1987
7. Amano K, Kawamura H, Tanikawa T, Kawabatake H, Iseki H, Iwata Y: Bilateral versus unilateral percutaneous high cervical cordotomy as a surgical method of pain relief. Acta Neurochirurgica - Supplementum 52:143-145, 1991
8. Andersen HB, Kjaergard J, Eriksen J: Subcutaneously implanted injection system for epidural administration. Acta Anaesthesiologica Scandinavica 30:473-476, 1986
9. Andersen PE, Cohen JI, Everts EC, Bedder MD, Burchiel KJ: Intrathecal narcotics for relief of pain from head and neck cancer. Archives of Otolaryngology -- Head & Neck Surgery 117:1277-1280, 1991
10. Arbit E, Galicich JH, Burt M, Mallya K: Modified open thoracic rhizotomy for treatment of intractable chest wall pain of malignant etiology. Ann Thorac Surg 48:820-823, 1989
11. Arner S, Arner B: Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiologica Scandinavica 29:32-36, 1985
12. Ashburn MA, Fine PG, Stanley TH: Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report. Anesthesiology 71:615-617, 1989
13. Ashby MA, Fleming BG, Brooksbank M, Rounsefell B, Runciman WB, Muirden N, Smith M: Description of a mechanistic approach to pain management in advanced cancer. Preliminary report. Pain 51:153-161, 1992
14. Bach F, Larsen BH, Rohde K, Borgesen SE, Gjerris F, Boge-Rasmussen T, Rasmusson B, Stjernholm P, Sorensen PS: Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochirurgica 107:37-43, 1990
15. Baines M, Oliver DJ, Carter RL: Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study. Lancet ii:990-993, 1985
16. Banning A, Sjogren P, Henriksen H: Treatment outcome in a multidisciplinary cancer pain clinic [see comments]. Pain 47:129-34; discussion 127, 1991
17. Barak F, Werner A, Walach N, et al: The palliative efficacy of a single high dose of radiation in treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 13:1233-1235, 1987(Abstract)
18. Barber J: Hypnosis as a psychological technique in the management of cancer pain. Cancer Nursing 1:361-363, 1978
19. Barkwell DP: Ascribed meaning: a critical factor in coping and pain attenuation in patients with cancer-related pain. Journal of Palliative Care 7:5-14, 1991
20. Batzdorf U, Brechner VL: Management of pain associated with the pancoaste syndrome. American Journal of Surgery 137:638-646, 1979
21. Baumann TJ, Batenhorst RL, Graves DA, Foster TS, Bennett RL: Patient-controlled analgesia in the terminally ill cancer patient. Drug Intelligence & Clinical Pharmacy 20:297-301, 1986
22. Bedder MD, Burchiel K, Larson A: Cost analysis of two implantable narcotic delivery systems. Journal Of Pain And Symptom Management 6:368-373, 1991
23. Bengtsson M, Lofstrom JB: Nerve block in pancreatic pain. Acta Chirurgica Scandinavica 156:285-291, 1990
24. Benson RC, Jr., Hasan SM, Jones AG, Schlise S: External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate. Journal of Urology 127:69-71, 1982
25. Benzon HT: Convulsions secondary to intravascular phenol: a hazard of celiac plexus block. Anesthesia and Analgesia 58:150-151, 1979
26. Berde CB, Fischel N, Filardi JP, Coe CS, Grier HE, Bernstein SC: Caudal epidural morphine analgesia for an infant with advanced neuroblastoma: report of a case. Pain 36:219-223, 1989
27. Bigler D, Christensen CB, Eriksen J, Jensen NH: Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration. Pain 41:15-18, 1990
28. Birnbaum PL, Mercer CD: Laser fulguration for palliation of rectal tumours. Canadian Journal of Surgery 33:299-301, 1990
29. Blanchard J, Menk E, Ramamurthy S, Hoffman J: Subarachnoid and epidural calcitonin in patients with pain due to metastatic cancer. Journal of Pain & Symptom Management 5:42-45, 1990
30. Boersma FP, Buist AB, Thie J: Epidural pain treatment in the northern Netherlands. Organizational and treatment aspects. Acta Anaesthesiologica Belgica 38:213-216, 1987
31. Boersma FP, Noorduin H, Vanden Bussche G: Epidural sufentanil for cancer pain control in outpatients. Regional Anesthesia 14:293-297, 1989
32. Bosch DA: Stereotactic rostral mesencephalotomy in cancer pain and deafferentation pain. A series of 40 cases with follow-up results [see comments]. Journal of Neurosurgery 75:747-751, 1991
33. Breivik H, Rennemo F: Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesthesiologica Scandinavica Supplementum 74:135-140, 1982
34. Brown DL: A retrospective analysis of neurolytic celiac plexus block for nonpancreatic intra-abdominal cancer pain. Regional Anesthesia 14:63-65, 1989
35. Brown DL, Bulley CK, Quiel EL: Neurolytic celiac plexus block for pancreatic cancer pain. Anesthesia & Analgesia 66:869-873, 1987
36. Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A: Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 62:407-411, 1988
37. Bruera E, Brenneis C, Michaud M, Chadwick S, MacDonald RN: Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer Treatment Reports 71:635-637, 1987
38. Bruera E, Brenneis C, Michaud M, Macmillan K, Hanson J, MacDonald RN: Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. Journal of the National Cancer Institute 80:1152-1154, 1988
39. Bruera E, Brenneis C, Paterson AH, MacDonald RN: Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. Journal of Pain & Symptom Management 4:3-6, 1989
40. Bruera E, Carraro S, Roca E, Barugel M, Chacon R: Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients. Cancer Treatment Reports 70:295-298, 1986
41. Bruera E, Fainsinger R, Moore M, Thibault R, Spoldi E, Ventafridda V: Local toxicity with subcutaneous methadone. Experience of two centers [see comments]. Pain 45:141-143, 1991
42. Bruera E, Legris MA, Kuehn N, Miller MJ: Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer. Journal of Pain & Symptom Management 5:218-220, 1990
43. Bruera E, MacDonald N, Brenneis C, Simpson I, LeGatt D: Metoclopramide infusion with a disposable pump. Annals of Internal Medicine 104(6):8961986
44. Bruera E, Macmillan K, Hanson J, MacDonald RN: Palliative care in a cancer center: results in 1984 versus 1987. Journal of Pain & Symptom Management 5:1-5, 1990
45. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN: A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279-1282, 1990
46. Bruera E, Macmillan K, Pither J, MacDonald RN: Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain & Symptom Management 5:341-344, 1990
47. Bruera E, Miller MJ: Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain. Pain 39:297-300, 1989
48. Bruera E, Miller MJ, Macmillan K, Kuehn N: Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48:163-166, 1992
49. Bruera E, Schoeller T, Fainsinger RL, Kastelan C: Custom-made suppositories of methadone for severe cancer pain. Journal Of Pain And Symptom Management 7:372-374, 1992
50. Bruera E, Schoeller T, Montejo G: Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 48:397-399, 1992
51. Bruera ED, Chadwick S, Bacovsky R, MacDonald N: Continuous subcutaneous infusion of narcotics using a portable disposable pump. Journal Of Palliative Care 1:46-47, 1985
52. Bryant DD, DeWitty RL, Jr., Dennis GC: The Infusaid pump in the management of intractable cancer pain. Journal of the National Medical Association 79:305-311, 1987
53. Buy JN, Moss AA, Singler RC: CT guided celiac plexus and splanchnic nerve neurolysis. Journal Of Computer Assisted Tomography 6:315-319, 1982
54. Campbell CF, Mason JB, Weiler JM: Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Annals Of Internal Medicine 98:51-52, 1983
55. Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A: The incidence of narcotic-induced emesis. Journal of Pain & Symptom Management 6:428-430, 1991
56. Caputi CA, Busca G, Fogliardi F, Giugliano F: Evaluation of tolerance in long-term treatment of cancer pain with epidural morphine. International Journal of Clinical Pharmacology, Therapy, & Toxicology 21:587-590, 1983
57. Carey PO, Lippert MC: Treatment of painful prostatic bone metastases with oral etidronate disodium. Urology 32:403-407, 1988
58. Carl P, Crawford ME, Ravlo O, Bach V: Longterm treatment with epidural opioids. A retrospective study comprising 150 patients treated with morphine chloride and buprenorphine. Anaesthesia 41:32-38, 1986
59. Carlisle DW, Smith KA, Frank E, Meyers FJ: Intraventricular morphine administered by hospice nurses to a patient in intractable pain. American Journal of Hospice Care 6(4):36-39, 1989
60. Carlson RW, Borrison RA, Sher HB, Eisenberg PD, Mowry PA, Wolin EM: A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain. Pharmacotherapy 10:211-216, 1990
61. Cassileth PA, Lusk EJ, Torri S, Di Nubile N, Gerson SL: Anti-emetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Archives of Internal Medicine 143:1347-1349, 1983
62. Caute B, Monsarrat B, Gouarderes C, Verdie JC, Lazorthes Y, Cros J: CSF morphine levels after lumbar intrathecal administration of isobaric and hyperbaric solutions for cancer pain. Pain 32:141-146, 1988
63. Chan A, Woodruff RK: Palliative care in a general teaching hospital. 1. Assessment of needs. Medical Journal of Australia 155:597-599, 1991
64. Choi CR, Ha YS, Ahn MS, Lee JS, Song JU: Intraventricular or epidural injection of morphine for severe pain. Neurochirurgia 32:180-183, 1989
65. Citron ML, Johnston-Early A, Boyer M, Krasnow SH, Hood M, Cohen MH: Patient-controlled analgesia for severe cancer pain. Archives of Internal Medicine 146:734-736, 1986
66. Citron ML, Johnston-Early A, Fossieck BE, Jr., Krasnow SH, Franklin R, Cohen MH: Safety and efficacy of continuous intravenous morphine for severe cancer pain. American Journal of Medicine 77:199-204, 1984
67. Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB: Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use. Cancer Investigation 10:335-341, 1992
68. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA: Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine 330:592-596, 1994
69. Cobb CA, French BN, Smith KA: Intrathecal morphine for pelvic and sacral pain caused by cancer. Surgical Neurology 22:63-68, 1984
70. Collins TM, Ash DV, Close HJ: An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus. Clin Radiol 39:284-286, 1988
71. Cook PR, Campbell FN, Puddy BR: Pituitary alcohol injection for cancer pain. Use in a district general hospital. Anaesthesia 39:540-545, 1984
72. Coombs DW, Maurer LH, Saunders RL, Gaylor M: Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. Journal of Clinical Oncology 2:1414-1420, 1984
73. Coombs DW, Saunders RL, Fratkin JD, Jensen LE, Murphy CA: Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. Journal of Neurosurgery 64:890-894, 1986
74. Coombs DW, Saunders RL, Gaylor MS, Block AR, Colton T, Harbaugh R, Mroz W: Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir. JAMA 250:2336-2339, 1983
75. Corssen G, Holcomb MC, Moustapha I, Langford K, Vitek JJ, Ceballos R: Alcohol-induced adenolysis of the pituitary gland: a new approach to control of intractable cancer pain. Anesthesia & Analgesia 56:414-421, 1977
76. Coyle N: A model of continuity of care for cancer patients with chronic pain. Medical Clinics Of North America 71:259-270, 1987
77. Coyle N: Continuity of care for the cancer patient with chronic pain. Cancer 63:2289-2293, 1989
78. Coyle N, Mauskop A, Maggard J, Foley KM: Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncology Nursing Forum 13:53-57, 1986
79. Coyle N, Monzillo E, Losalzo M, Farkas C, Massie MJ, Foley KM: A model of continuity of care for cancer patients with pain and neuro-oncologic complications. Cancer Nursing 8:111-119, 1985
80. Crul BJ, Delhaas EM: Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases. Regional Anesthesia 16:209-213, 1991
81. Cubeddu LX, Pendergrass K, Ryan T, York M, Burton G, Meshad M, Ciociola AA: Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group [see comments]. American Journal of Clinical Oncology 17:137-146, 1994
82. De Conno F, Caraceni A, Aldrighetti L, Magnani G, Ferla G, Comi G: Paraplegia following coeliac plexus block. Pain 55:383-385, 1993
83. De Conno F, Ripamonti C, Sbanotto A, Barletta L, Zecca E, Martini C: A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine in cancer pain. Journal of Pain & Symptom Management 6:423-427, 1991
84. de Cuyper C, Goeteyn M: Systemic contact dermatitis from subcutaneous hydromorphone. Contact Dermatitis 27:220-223, 1992
85. de Leon-Casasola OA, Kent E, Lema MJ: Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 54:145-151, 1993
86. DeChristoforo R, Corden BJ, Hood JC, Narang PK, Magrath IT: High-dose morphine infusion complicated by chlorobutanol-induced somnolence. Annals Of Internal Medicine 98:335-336, 1983
87. Dennis GC, DeWitty R: Management of intractable pain in cancer patients by implantable morphine infusion systems. Journal of the National Medical Association 79:939-944, 1987
88. Dennis GC, DeWitty RL: Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. Neurosurgery 26:404-7; discussion 407, 1990